Company Filing History:
2 out of 3,477 
2 out of 21 
1 out of 11 Years Active: 2013
Title: Daisuke Akazawa: Innovator in Hepatitis C Research
Introduction
Daisuke Akazawa is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of infectious diseases, particularly in the development of vaccines for hepatitis C virus (HCV). With a total of 2 patents, his work has the potential to impact public health positively.
Latest Patents
One of his latest patents is titled "Nucleic acid comprising chimeric gene derived from hepatitis C virus." This invention provides infectious chimeric HCV particles that can be utilized for vaccines. It further details a nucleic acid comprising a chimeric gene derived from the hepatitis C virus, which includes various proteins from different strains. Another notable patent is "Antibody having activity of inhibiting hepatitis C virus (HCV) infection and use thereof." This invention aims to provide an antibody that inhibits HCV infection by recognizing and binding to the virus, thereby preventing it from attaching to host cells.
Career Highlights
Daisuke Akazawa has worked with notable organizations such as Toray Industries, Inc. and the National Institute of Infectious Diseases in Japan. His experience in these institutions has allowed him to collaborate on groundbreaking research in the field of infectious diseases.
Collaborations
Throughout his career, Akazawa has collaborated with esteemed colleagues, including Takaji Wakita and Kazumi Nishimura. These partnerships have contributed to the advancement of research and innovation in hepatitis C treatment.
Conclusion
Daisuke Akazawa's contributions to hepatitis C research through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in vaccine development and therapeutic interventions.